TY - JOUR
T1 - Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
AU - Brazda, Peter
AU - Ruiz-Moreno, Cristian
AU - Megchelenbrink, Wout L.
AU - Timmers, Henri J.L.M.
AU - Stunnenberg, Hendrik G.
N1 - Copyright © 2022 Brazda, Ruiz-Moreno, Megchelenbrink, Timmers and Stunnenberg.
PY - 2022/8/15
Y1 - 2022/8/15
N2 - Pheochromocytoma, neuroendocrine tumor, single cell RNA-sequencing, transcriptome, heterogeneity, SDHB, RET, paraganglinoma; Pheochromocytomas (PC) and paragangliomas (PG) are rare neuroendocrine tumors with varied genetic makeup and are associated with high cardiovascular morbidity and a variable risk of malignancy. The source of the transcriptional heterogeneity of the disease and the underlying biological processes that determine the outcome of PCPG remain largely unclear. We focused on PCPG tumors with germline SDHB and RET mutations, which represent distinct prognostic groups with worse or better prognoses, respectively. We applied single-nuclei RNA sequencing (snRNA-seq) to tissue samples from 11 patients and found high patient-to-patient transcriptome heterogeneity in neuroendocrine tumor cells. The tumor microenvironment also showed heterogeneous profiles, mainly contributed by macrophages of the immune cell clusters and Schwann cells of the stroma. By performing non-negative matrix factorization, we identified common transcriptional programs active in RET and SDHB, as well as distinct modules, including neuronal development, hormone synthesis and secretion, and DNA replication. Similarities between the transcriptomes of the tumor cells and those of the chromaffin- and precursor cell types suggests different developmental stages at which PC and PG tumors appear to be arrested.
AB - Pheochromocytoma, neuroendocrine tumor, single cell RNA-sequencing, transcriptome, heterogeneity, SDHB, RET, paraganglinoma; Pheochromocytomas (PC) and paragangliomas (PG) are rare neuroendocrine tumors with varied genetic makeup and are associated with high cardiovascular morbidity and a variable risk of malignancy. The source of the transcriptional heterogeneity of the disease and the underlying biological processes that determine the outcome of PCPG remain largely unclear. We focused on PCPG tumors with germline SDHB and RET mutations, which represent distinct prognostic groups with worse or better prognoses, respectively. We applied single-nuclei RNA sequencing (snRNA-seq) to tissue samples from 11 patients and found high patient-to-patient transcriptome heterogeneity in neuroendocrine tumor cells. The tumor microenvironment also showed heterogeneous profiles, mainly contributed by macrophages of the immune cell clusters and Schwann cells of the stroma. By performing non-negative matrix factorization, we identified common transcriptional programs active in RET and SDHB, as well as distinct modules, including neuronal development, hormone synthesis and secretion, and DNA replication. Similarities between the transcriptomes of the tumor cells and those of the chromaffin- and precursor cell types suggests different developmental stages at which PC and PG tumors appear to be arrested.
KW - heterogeneity
KW - neuroendcrine tumor
KW - paraganglinoma
KW - pheochromocytoma
KW - RET
KW - SDHB
KW - single cell RNA seq
KW - transcriptome
UR - http://www.scopus.com/inward/record.url?scp=85136856533&partnerID=8YFLogxK
U2 - 10.3389/fonc.2022.965168
DO - 10.3389/fonc.2022.965168
M3 - Article
C2 - 36046044
AN - SCOPUS:85136856533
SN - 2234-943X
VL - 12
SP - 965168
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 965168
ER -